Skadden Reps JLL Partners-Backed Co. In Biopharma Deal
JLL Partners-backed DPx Holdings BV said Wednesday it will acquire Gallus BioPharmaceuticals from Ridgemont Equity Partners for an undisclosed amount in a deal that would make the combined company a leading provider...To view the full article, register now.
Already a subscriber? Click here to view full article